Results 11 to 20 of about 92,957 (241)
Addressing an HIV cure in LMIC [PDF]
Retrovirology, 2021 HIV-1 persists in infected individuals despite years of antiretroviral therapy (ART), due to the formation of a stable and long-lived latent viral reservoir.
Sherazaan D. Ismail +7 more
semanticscholar +5 more sources
Advancing Tobacco Cessation in LMICs
Current Oncology, 2022 Tobacco kills more than 8 million people worldwide every year. Over 80% of the world’s 1.3 billion tobacco users live in low- and middle-income countries (LMICs), where the future burden is projected to grow. At the same time, progress in tobacco control has not advanced as far as in many LMICs.
Abhishek Shankar +5 more
openaire +3 more sources
Frontiers in Psychiatry, 2022 Background There is a multitude of systematic reviews of interventions for children and adolescents with autism spectrum disorder (ASD). However, most reviews seem to be based on research conducted in High-Income Countries (HIC).
Maleka Pervin, H. Ahmed, Y. Hagmayer
semanticscholar +1 more source
The COVID-19 pandemic and the challenge of using technology for medical education in low and middle income countries [PDF]
, 2020 The current use of technology for medical education in low and middle income countries (LMIC) during the COVID-19 pandemic is not yet reaching its potential. We provide recommendations for LMIC that has focus on a systematic framework that considers both
Cecilio-Fernandes, Dario +3 more
core +1 more source
Biobanking in LMIC settings for infectious diseases: Challenges and enablers
Biosafety and Health, 2022 Highlights • Most biobanks in low-and middle-income countries (LMICs) have been set as part of specific project, thus resulting to a fragmented and siloed infrastructure landscape.• Current biobanking challenges are represented by the following thematic ...
S. Ezzat, Ruzica Biga, Z. Kozlakidis
semanticscholar +1 more source
Is Aducanumab for LMICs? Promises and Challenges [PDF]
Brain Sciences, 2021 Aducanumab, a human monoclonal antibody, was approved in June of 2021 as the first disease-modifying treatment for Alzheimer’s disease by the United States Food and Drug Administration (U.S. FDA). A substantial proportion of patients with Alzheimer’s disease live in low- and middle-income countries (LMICs), and the debilitating effects of this disease ...
Illangage P. C. Gunawardena +2 more
openaire +3 more sources
Initial experience of a geriatric oncology clinic in a tertiary cancer center in India
Cancer Research, Statistics, and Treatment, 2020 Background: Little is known about the comprehensive geriatric assessment (CGA) profile of Indian patients. We aimed to describe the CGA results of the Indian geriatric oncology patients and identify the incidence of polypharmacy.
Vanita Noronha +15 more
doaj +1 more source
Clinical and Experimental Obstetrics & Gynecology, 2023 Background: Postpartum hemorrhage (PPH) is the most common cause of maternal mortality in low-and middle-incomes countries (LMICs). It is treated surgically when first line treatments fail.
Dehi Boston Mian +6 more
doaj +1 more source
Teaching and learning in medicine, 2022 Phenomenon Medical educators are particularly needed in Low- and Middle-Income Countries (LMIC), where medical schools have grown rapidly in size, number, and global outlook in response to persistent health workforce shortages and increased expectations
Wendy C. Y. Hu +3 more
semanticscholar +1 more source
Nutrients, 2021 Background: This study aimed to describe the epidemiology of malnutrition among children with cerebral palsy (CP) in low- and middle-income countries (LMICs). Methods: Data from children with confirmed CP aged
Israt Jahan +9 more
semanticscholar +1 more source